Skip to content

A retrospective survey on herpes zoster prevention with varicella vaccine

A retrospective survey on the prevention of herpes zoster through the VARICELLA VACCINE LIVE ATTENUATED "BIKEN" - A retrospective survey on the prevention of herpes zoster through the VARICELLA VACCINE LIVE ATTENUATED "BIKEN"

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000045026
Enrollment
1830
Registered
2021-08-02
Start date
2021-08-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes Zoster

Interventions

None listed

Sponsors

SOUSEIKAI
Lead Sponsor
Osaka City University Graduate School of Medicine Department of Public Health
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Those who are over 50 years old 2) Those who have provided the written consent to participate in this study

Exclusion criteria

Exclusion criteria: Those who have been vaccinated with a freeze-dried recombinant herpes zoster vaccine.

Design outcomes

Primary

MeasureTime frame
The effectiveness of the varicella vaccine against herpes zoster will be evaluated by analyzing statistically the frequency of herpes zoster onsets between each group and the background of the study subjects.

Countries

Japan

Contacts

Public ContactHiroko Kumashiro

SOUSEIKAI Department of strategy & business development

Hiroko-kumashiro@lta-med.com092-409-1914

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026